Emerging Medicinal Chemistry of the YEATS4 Epigenetic Reader
YEATS4 (GAS41) is an acyllysine reader and a component of chromatin-remodelling complexes. Its amplification or overexpression in multiple malignancies, together with functional studies, link it to tumour growth. This has prompted efforts to develop YEATS4 ligands as chemical probes and potential anticancer agents. This review examines the structural basis of histone recognition by the YEATS4 YEATS domain and surveys the discovery, synthesis, structure–activity relationships, and biological evaluation of the ligands reported so far. We compare the thiophene-based monovalent and bivalent inhibitors, bicyclic heteroaryl–piperidine carboxamides, and emerging benzimidazole and arylthiophene series. Despite progress from fragment hits to potent ligands with cellular activity, YEATS4 inhibitor development is still at an early stage, with only a few inhibitor series reported to date and key challenges remaining.
Authors
- Piotr F. J. Lipiński (ORCID: https://orcid.org/0000-0002-8364-7955)
- Jolanta Dyniewicz (ORCID: https://orcid.org/0000-0002-1932-4019)
Institutions
- Mossakowski Medical Research Institute, Polish Academy of Sciences (PL)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/ijms272210429
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00